Suits
06-03-2010 |
15:57 hs.
Biogen Idec Inc. filed a lawsuit against several pharmaceutical companies (Pfizer, Merck KGaA, Bayer AG and Novartis) for Avonex (Interferon Beta 1a).patent infringement. The drug is indicated to treat multiple sclerosis.
05-25-2010 |
21:03 hs.
Genzyme Corp. filed a lawsuit in Delaware District Court against Novartis AG unit Sandoz, for patent infringement for its Hectorol drug to lower the parathyroid hormone in patients suffering from kidney disease.
04-14-2010 |
16:43 hs.
Pozen Inc. and Teva Pharmaceutical Industries Ltd., announced agreement to conclude legal dispute over Treximet, indicated to treat migraine. The product is marketed in the United States by GlaxoSmitnKline Plc.
Patent Extension Challenge
03-26-2010 |
14:38 hs.
U.S. based The Medicines Company dared the U.S. Patent and Trademark Office (PTO) decision to deny a patent extension for its anti-clotting drug, Angiomax (Bivalirudin)
Oftatunumab
03-25-2010 |
17:15 hs.
According to British drug maker GlaxoSmithKline Plc. and Danish based Genmab A/S were sued by US based Biogen Idec and Swiss based Roche Holding AG for alleged patent infringement of chronic lymphocytic leukemia drug Arzerra (oftatumumab). The drug was approved back in October 2009.
J&J Arbitration
05-29-2009 |
15:16 hs.
US based Johnson & Johnson filed for arbitration to terminate a marketing agreement over Remicade (Infliximab) and Simponi (Golimumab) with Schering-Plough Corp, after signed acquisition with rival Merck & Co.
11-19-2008 |
15:50 hs.
Indianapolis-based drug maker Eli Lilly & Co. sued Cobalt Laboratories Inc., Impax Laboratories Inc., Sandoz Inc. and Wockhardt Ltd., after the companies filed abbreviated new drug applications to sell duloxetine, the active ingredient of the anti-depressant Cymbalta. The blockbuster drug patent expires in 2013.
Merck/Schering-Plough questioned by U.S. prosecutors
11-05-2008 |
12:33 hs.
Federal and state prosecutors are investigating whether Merck & Co and Schering-Plough Corp improperly promoted the cholesterol-fighting medication Vytorin, adding to the government probes and private lawsuits involving the jointly marketed drug.
Allege being misled by company
10-09-2008 |
11:15 hs.
Canadian drugmaker Biovail Corp reported it is being sued by investors who allege it made misleading statements during the approval process for the depression drug Aplenzin.
Lawsuit seeking $ 4.9 B for civil fraud
10-08-2008 |
10:30 hs.
According to documents submitted in a U.S. consolidated lawsuit by health insurers and consumers against Pfizer Inc., the company suppressed information from medical studies that did not support the use of its epilepsy drug Neurontin as a drug for other conditions besides epilepsy. Plaintiffs are seeking $ 4.9 billion dollars in damages for alleged civil fraud.
10-01-2008 |
12:55 hs.
Indianapolis-based Eli Lilly & Co. has filed a lawsuit against Israel´s generic-drug maker Teva Pharmaceutical Industries Ltd., alleging infringement of two U.S. patents used for its cancer drug Gemzar (gemcitabine).
09-02-2008 |
12:57 hs.
For MS drug Copaxone
08-29-2008 |
09:50 hs.
World’s largest generics maker Teva Pharmaceutical Ind Ltd announced is has filed a lawsuit against Switzerland´s Novartis AG and U.S. drugmaker Momenta Pharmaceuticals Inc. for patent infringement of its multiple sclerosis treatment Copaxone. Teva claims the patents are valid and enforceable through 2014 and 2015. Further details.
08-12-2008 |
10:07 hs.
Patents expire in 2014
08-05-2008 |
13:12 hs.
Germany's Bayer AG is suing Novartis AG's Sandoz unit to prevent it from selling a copy of the Yaz birth-control pill in the U.S. Bayer is seeking to block approval of the generic version until two patents on the drug expire in 2014.
Patents expire in 2013
07-29-2008 |
12:43 hs.
Swiss giant drugmaker Novartis announced it has filed a lawsuit in the U.S. against Israeli generics firm Teva, over patents for Zometa and Reclast, the company´s bone disease treatment drugs. Further details.
Generic not yet approved by FDA
07-29-2008 |
11:11 hs.
Barr Pharmaceuticals Inc. announced it is being sued by Amgen Inc. over a challenge to the biotechnology company´s hyperparathyroidism drug Sensipar. Further details.
Record Vioxx Settlement
07-17-2008 |
14:13 hs.
Merck & Co said that over 97 percent of eligible U.S. claimants have accepted to enter into a record $4.85 billion Vioxx settlement, one of the largest civil settlements ever
07-11-2008 |
09:12 hs.
A 55-year-old former Wall Street banker is suing drugmakers involved with Parkinson’s disease drug Mirapex over his $3 million gambling losses
FDA warning “too little, too late”
07-10-2008 |
12:14 hs.
The widow of a man who allegedly committed suicide after using Pfizer Inc.´s smoking-cessation treatment Chantix, filed a lawsuit against the world number one drugmaker, claiming Pfizer failed to properly warn of the pill´s psychiatric side effects. Lawyer believes this suit will kick off many more Chantix litigations. Further details.
